BioSpace News Archive

Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer, today announced that it will report second quarter 2022 financial results on Tuesday, August 9, 2022, after the close of the market.

Berkeley Lights, Inc. and Aanika Biosciences today announced that the companies have successfully reached their strategic partnership milestone by identifying a commercially viable antimicrobial peptide (AMP) to enable faster identification of outbreak sources, reduce incidents of fresh produce contamination and minimize the impact of food borne illness related recalls.

GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will host a conference call and webcast to report second quarter financial results on Wednesday, August 3, 2022, at 8:30 a.m. ET.

Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, will present at the following investor conferences in August:

Apyx Medical Corporation, the manufacturer of proprietary helium plasma and radiofrequency technology products marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, announced its first reporting of environmental, social and governance data via a newly released tear sheet.

Orthofix Medical Inc., a global medical device company with a spine and orthopedics focus, announced that it will release its second quarter 2022 financial results before market open on Friday, August 5, 2022.

Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, announced today it will report financial results for the second quarter of 2022 after market close on Wednesday, August 10, 2022.

Tenon Medical, Inc., a medical device company that has developed a proprietary, U.S. Food and Drug Administration cleared surgical implant system for sacroiliac joint fixation/fusion surgery, announced plans to release financial results for the second quarter ended June 30, 2022 after market close on Thursday, August 11, 2022.

Danimer Scientific, a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced that the Company will release its second quarter 2022 financial results after the market closes on Tuesday, August 9, 2022.

Dyadic International, Inc. announced that it will report its financial results for the second quarter 2022 and host a corporate update conference call on Wednesday, August 10, 2022.